CHAD N ADAMS

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical ODESSA, TX NPI 1750893152

General Payments — all program years on this page

$1,993.30

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 122
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $316.87 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $316.8720

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $137.489
Novo Nordisk AS $52.433
PFIZER INC. $43.953
Lilly USA, LLC $34.092
Abbott Laboratories $16.851
Exact Sciences Corporation $16.411
Amgen Inc. $15.661

By program year

Program yearAmountRecords
2021 $449.2027
2022 $648.9736
2023 $578.2639
2024 $316.8720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100231560 Novo Nordisk Inc $15.46 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100405549 Novo Nordisk Inc $17.92 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100642732 Novo Nordisk Inc $19.05 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104265333 AstraZeneca Pharmaceuticals LP $21.43 06/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104270463 AstraZeneca Pharmaceuticals LP $15.98 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104467370 AstraZeneca Pharmaceuticals LP $13.13 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104587080 AstraZeneca Pharmaceuticals LP $2.92 06/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105352889 AstraZeneca Pharmaceuticals LP $20.23 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105616519 AstraZeneca Pharmaceuticals LP $15.12 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105639612 AstraZeneca Pharmaceuticals LP $13.48 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105676077 AstraZeneca Pharmaceuticals LP $13.84 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105688723 AstraZeneca Pharmaceuticals LP $21.35 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114534524 Exact Sciences Corporation $16.41 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117489042 Amgen Inc. $15.66 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125248842 Abbott Laboratories $16.85 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131706400 PFIZER INC. $13.96 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131745928 PFIZER INC. $16.51 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131995777 PFIZER INC. $13.48 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135581126 Lilly USA, LLC $17.69 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135581128 Lilly USA, LLC $16.40 09/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.